Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $493.26 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $122.90 | 1 | $0 (2021) |
| Relypsa, Inc. | $108.96 | 3 | $0 (2017) |
| Amgen Inc. | $107.47 | 4 | $0 (2017) |
| Mallinckrodt LLC | $92.52 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $50.94 | 3 | $0 (2018) |
| BAXTER HEALTHCARE | $10.47 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $122.90 | 1 | Aurinia Pharma U.S., Inc. ($122.90) |
| 2018 | $50.94 | 3 | Otsuka America Pharmaceutical, Inc. ($50.94) |
| 2017 | $319.42 | 9 | Relypsa, Inc. ($108.96) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $122.90 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/27/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: NEPHROLOGY | ||||||
| 07/10/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEPHROLOGY | ||||||
| 06/15/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEPHROLOGY | ||||||
| 12/06/2017 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $94.80 | General |
| Category: Nephrology | ||||||
| 10/20/2017 | Amgen Inc. | Sensipar (Drug) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Nephrology | ||||||
| 06/02/2017 | BAXTER HEALTHCARE | Renal - PD (Device) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Renal | ||||||
| 05/24/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $100.98 | General |
| Category: Hyperkalemia | ||||||
| 05/02/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: Hyperkalemia | ||||||
| 03/30/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $92.52 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 03/06/2017 | Amgen Inc. | Parsabiv (Biological), Sensipar | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: Nephrology | ||||||
| 01/20/2017 | Amgen Inc. | Sensipar (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Nephrology | ||||||
| 01/17/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 291 | 382 | $87,838 | $30,375 |
| 2022 | 7 | 341 | 506 | $100,229 | $34,148 |
| 2021 | 9 | 391 | 551 | $109,579 | $39,649 |
| 2020 | 7 | 159 | 251 | $44,661 | $15,108 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 129 | $32,249 | $11,902 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $23,312 | $7,334 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 58 | $10,307 | $3,369 | 32.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 55 | $9,056 | $3,325 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $8,262 | $2,654 | 32.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 34 | 52 | $4,652 | $1,791 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 113 | $26,938 | $9,648 | 35.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 69 | 148 | $24,272 | $8,324 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $21,056 | $6,511 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 76 | $12,978 | $4,529 | 34.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 49 | 70 | $6,516 | $2,109 | 32.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 23 | 25 | $5,541 | $1,997 | 36.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 11 | 18 | $2,928 | $1,031 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 98 | $23,128 | $9,758 | 42.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 152 | $24,914 | $8,687 | 34.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 66 | 66 | $24,816 | $7,892 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 70 | $11,830 | $4,597 | 38.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 55 | 92 | $8,424 | $2,830 | 33.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 30 | $6,855 | $2,432 | 35.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,618 | $1,295 | 35.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 15 | 16 | $3,550 | $1,283 | 36.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 11 | 15 | $2,444 | $874.50 | 35.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 79 | $12,986 | $4,612 | 35.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $10,152 | $3,233 | 31.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 34 | $5,746 | $1,918 | 33.4% |
About Dr. Alisa Bell, DO
Dr. Alisa Bell, DO is a Nephrology healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316913403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alisa Bell, DO has received a total of $493.26 in payments from pharmaceutical and medical device companies, with $122.90 received in 2021. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($493.26).
As a Medicare-enrolled provider, Bell has provided services to 1,182 Medicare beneficiaries, totaling 1,690 services with total Medicare billing of $119,280. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Lancaster, PA
- Active Since 02/27/2006
- Last Updated 01/18/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1316913403
Products in Payments
- LUPKYNIS (Drug) $122.90
- Veltassa (Drug) $108.96
- Parsabiv (Biological) $99.01
- ACTHAR (Biological) $92.52
- JYNARQUE (Drug) $50.94
- Renal - PD (Device) $10.47
- Sensipar (Drug) $8.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Lancaster
Dr. Bassel Hadaya, M.d, M.D
Nephrology — Payments: $4,413
Dr. Jeffrey Martin, Md, MD
Nephrology — Payments: $3,980
Dr. Nanette Fonte, M.d, M.D
Nephrology — Payments: $3,464
Dr. Sung Yang, Md, MD
Nephrology — Payments: $3,188
Dr. Rendell Manalo, D.o, D.O
Nephrology — Payments: $2,636
Dr. Susan Ciampaglia, Do, DO
Nephrology — Payments: $1,384